文献速递肝病

氨在肝硬化患者中的预后作用

Prognostic Role of Ammonia in Patients With Cirrhosis.
PubMed 文献 · Hepatology · 2019-03-21

研究基于两家机构498例肝硬化患者的前瞻性观察数据,发现血浆氨水平与肝性脑病严重程度相关,在非存活者中显著更高,是28天死亡的独立预测因子;氨≥79.5 µmol/L与器官衰竭频率更高相关,第5天氨水平未改善者死亡率达70.6%。

要点

  • 血浆氨水平与肝性脑病严重程度相关(P < 0.001)。
  • 氨≥79.5 µmol/L预测28天死亡的敏感度68.1%、特异度67.4%。
  • 第5天基线氨未改善者死亡率达70.6%。

核心结论

  • 氨水平不仅与肝性脑病严重程度相关,还与其他器官衰竭相关,是死亡的独立危险因素。
  • 氨水平未改善与高死亡风险相关,使其成为重要生物标志物和治疗靶点。

研究设计与样本

  • 来自两家机构的前瞻性观察性研究,纳入498例肝硬化患者。
  • 入院时测量血浆氨水平,采用慢性肝衰竭-序贯器官衰竭评估标准判定器官衰竭,确定28天患者生存。
  • 采用受试者工作特征分析确定氨值的截断点,并使用Cox比例风险回归模型进行多变量分析。

主要发现

  • 28天死亡率为43.4%。
  • 血浆氨与肝性脑病严重程度相关(P < 0.001)。
  • 非存活者血浆氨显著高于存活者(93 [73-121] µmol/L vs 67 [55-89] µmol/L,P < 0.001)。
  • 氨是28天死亡的独立预测因子(风险比1.009,P < 0.001)。
  • 氨水平≥79.5 µmol/L与更高频率的器官衰竭相关:肝脏(P = 0.004)、凝血(P < 0.001)、肾脏(P = 0.004)、呼吸(P < 0.001)。

关键数值与推荐

  • 氨水平79.5 µmol/L预测28天死亡的敏感度为68.1%、特异度为67.4%。
  • 氨水平≥79.5 µmol/L与肝脏(P = 0.004)、凝血(P < 0.001)、肾脏(P = 0.004)、呼吸(P < 0.001)器官衰竭频率更高相关。
  • 非存活者血浆氨为93 [73-121] µmol/L,存活者为67 [55-89] µmol/L(P < 0.001)。
  • 氨对28天死亡的多变量风险比为1.009(P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ammonia is thought to be central to the pathogenesis of hepatic encephalopathy (HE), but its prognostic role in patients with cirrhosis and acute decompensation is unknown. The aims of this study were to determine the relationship between ammonia levels and severity of HE and its association with organ dysfunction and short-term mortality. We identified 498 patients from two institutions as part of prospective observational studies in patients with cirrhosis. Plasma ammonia levels were measured on admission and Chronic Liver Failure-Sequential Organ Failure Assessment criteria were used to determine the presence of organ failures. The 28-day patient survival was determined. Receiver operating characteristic analysis was used to identify the cutoff points for ammonia values, and multivariable analysis was performed using the Cox proportional hazard regression model. The 28-day mortality was 43.4%. Plasma ammonia correlated with severity of HE (P < 0.001), was significantly higher in nonsurvivors (93 [73-121] versus 67 [55-89] µmol/L, P < 0.001), and was an independent predictor of 28-day mortality (hazard ratio, 1.009, P < 0.001). An ammonia level of 79.5 µmol/L had sensitivity of 68.1% and specificity of 67.4% for predicting 28-day mortality. An ammonia level of ≥79.5 µmol/L was associated with a higher frequency of organ failures (liver [P = 0.004], coagulation [P < 0.001], kidney [P = 0.004], and respiratory [P < 0.001]). Lack of improvement in baseline ammonia at day 5 was associated with high mortality (70.6%). Conclusion: Ammonia level correlates with not only the severity of HE but also the failure of other organs and is an independent risk factor for mortality; lack of improvement in ammonia level is associated with high risk of death, making it an important biomarker and a therapeutic target.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Shalimar, Sheikh MF, Mookerjee RP, et al. Prognostic Role of Ammonia in Patients With Cirrhosis. Hepatology. 2019. PMID: 30703853. doi:10.1002/hep.30534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。